AbbVie Inc. (ABBV) Stock Analysis

AbbVie Inc. (ABBV) Stock Analysis — AI Research | MarketCI

ABBV

Market Closed

AbbVie Inc.

NYSEHealthcare Drug Manufacturers - General

55.00K employees

CEO: Robert A. Michael

Founded: 2013

$251.52

+$0.00(+NaN%)

Market Cap

444.38B

Beta

0.31

52W Range

N/A

Dividend Yield

2.68%

Overview Forecasts Fundamental Market Sentiment Valuation Ownership

ABBV Price Chart

Historical price performance

Loading MCI price data...

MarketCI Investment Signals

AI-synthesized investment signal for ABBV built from valuation, fundamentals, sentiment, and risk models

Investment Signal

Strong Sell

Pass %

42.86%

Score

3/7

Fair Value Estimate

Cash flow analysis • Multiple methods

$139.99

AI Price Target

Machine learning • Price prediction

$206.95

Market Sentiment

News & social media analysis

0.17

Value Investor Price

Classic value analysis

$11.72

Financial Health

Bankruptcy risk assessment

1.98

Quality Score

Financial strength rating

6.00

AI Investment Grade

Deep analysis of filings & news

75.00

Key Investment Highlights

Important factors affecting ABBV investment thesis

Due Diligence Analysis

Investment criteria assessment and scoring

Overall Assessment

47.62% Poor

Conditions Met

20.00/42.00

Due Diligence Score

47.62%

Due Diligence Conditions

Investment analysis conditions and results


	Fail
	Fail
	Pass
	Fail
	Fail
	Fail

Showing 1 to 6 of 46 conditions